IMP dehydrogenase inhibitor, tiazofurin, induces apoptosis in K562 human erythroleukemia cells

Communications in Clinical Cytometry

Volumn 30, Issue 1, 1997, Pages 61-66

  Vitale, Marco ^a,b,g   Zamai, Loris ^c   Falcieri, Elisabetta ^b,d   Zauli, Giorgio ^e   Gobbi, Pietro ^c   Santi, Spartaco ^b   Cinti, Caterina ^b   Weber, George ^f  

^a UNIVERSITY OF BRESCIA   (Italy)

^b Ist Citomorfologia Normale P   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d UNIVERSITY OF URBINO   (Italy)

^e UNIVERSITY OF FERRARA   (Italy)

^f INDIANA UNIVERSITY   (United States)

^g Dipto Sci Biomediche Biotecnologie   (Italy)

Author keywords

apoptosis; differentiation; K562; tiazofurin

Indexed keywords

GUANOSINE; GUANOSINE TRIPHOSPHATE; HYPOXANTHINE; INOSINATE DEHYDROGENASE; TIAZOFURIN;

APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; ERYTHROLEUKEMIA; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; ONCOGENE MYC; ONCOGENE RAS; PRIORITY JOURNAL; ULTRASTRUCTURE;

APOPTOSIS; DNA FRAGMENTATION; ENZYME INHIBITORS; FLOW CYTOMETRY; GUANOSINE TRIPHOSPHATE; HUMANS; HYPOXANTHINE; IMP DEHYDROGENASE; LEUKEMIA, ERYTHROBLASTIC, ACUTE; RIBAVIRIN; TUMOR CELLS, CULTURED;

EID: 0030916139     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0320(19970215)30:1<61::AID-CYTO9>3.0.CO;2-I     Document Type: Article

References (26)

1. Sen S, D'Incalci M: Apoptosis: Biocemical events and relevance to cancer chemotherapy. Fed Eur Biochem Soc 307:122-127, 1992.
2. Lowe SW, Ruley HE, Jacks T, Housman DE: p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74:957-967, 1993.
3. Williams GT, Smith CA: Molecular regulation of apoptosis: Genetic controls on cell death. Cell 74:777-779, 1993.
4. Cohen JJ: Apoptosis. Immunology Today, 14:126-130, 1993.
5. Xiong X, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D: p21 is a universal inhibitor of cyclin kinases. Nature 366:701-704, 1993.
6. Amati B, Littlewood TD, Evan GI, Land H: The c-Myc protein induces cell cycle progression and apoptosis through dimerization with Max. EMBO J 12:5083-5087, 1993.
7. Boguski MS, McCormick F: Proteins regulating Ras and its relatives. Nature 366:643-654, 1993.
8. Olah E, Natsumeda Y, Ikegami T, Kote Z, Horanyi M, Szelenyi J, Paulik E, Kremmer T, Hollan SR, Sugar J, Weber G: Induction of erythroid differentiation and modulation of gene expression by tiazofurin in K-562 leukemia cells. Proc Natl Acad Sci USA 85:6533-6537, 1988.
9. Tricot GJ, Jayaram HN, Weber G, Hoffman R: Tiazofurin: Biological effects and clinical uses. Int J Cell Cloning 8:161-170, 1990.
10. Weber G, Nagai M, Natsumeda Y, Eble JN, Jayaram HN, Paulik E, Zhen W, Hoffman R, Tricot G: Tiazofurin down-regulates expression of c-Ki-ras oncogene in a leukemic patient. Cancer Commun 3:61-66, 1991.
11. Lozzio CB, Lozzio BB: Human chronic myelogenous leukemia cell line with positive Philadelphia chromosome. Blood 45:321-328, 1975.
12. Zamai L, Zauli G, Bavelloni A, Marmiroli S, Cataldi A, Weber G, Vitale M: Tiazofurin induces a down-modulation of Icam-1 expression on K562 target cells impairing NK adhesion and killing. Cell Immunol 164:100-104, 1995.
13. Holm C, Covey JM, Kerrigan D, Pommier Y: Differential requirement of DNA replication for the cytotoxicity of DNA topoisomerase I and II inhibitors in Chinese hamster DC3F cells. Cancer Res 49:6365-6368, 1989.
14. Vitale M, Zamai L, Mazzotti G, Cataldi A, Falcieri E: Differential kinetics of propidium iodide uptake in apoptotic and necrotic thymocytes. Histochemistry 100:223-229, 1993.
15. Zamai L, Falcieri E, Marhefka G, Vitale M: Supravital exposure to propidium iodide identifies apoptotic cells in the absence of nucleosomal DNA fragmentation. Cytometry 23:303-311, 1996.
16. Falcieri E, Gobbi P, Sabatelli P, Santi S, Farabegoli F, Rana R, Cataldi A, Maraldi NM, Martelli AM: A combined ultrastructural approach to the study of nuclear matrix thermal stabilization. Histochemistry 98:121-129, 1992.
17. De La Torre J, Summer AT, Gosalvez J, Stuppia L: The distribution of genes on human chromosomes as studied by in-situ nick translation. Genome 35:890-896, 1992.
18. Falcieri E, Martelli AM, Bareggi R, Cataldi A, Cocco L: The protein kinase inhibitor staurosporin induces morphological changes typical of apoptosis in Molt-4 cells without concomitant DNA fragmentation. Biochem Biophys Res Commun 193:19-25, 1993.
19. Hata Y, Natsumeda Y, Weber G: Tiazofurin decreases Ras-GTP complex in K562 cells. Oncol Res 5:161-164, 1993.
20. Fanidi A, Harrington EA, Evan GI: Cooperative interaction between c-myc and bcl-2 prot-oncogenes. Nature 359:554-556, 1992.
21. Bissonnette RP, Echeverri F, Mahboubi A, Green DR: Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 359:552-554, 1992.
22. Shi Y, Glynn JM, Guilbert LJ, Cotter TG, Bissonnette RP, Green DR: Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas. Science 257:212-214, 1992.
23. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ, Handcock DC: Induction of apoptosis in fibroblasts by c-myc protein. Cell 69:119-128, 1992.
24. Arends MJ, Wyllie AH: Apoptosis: Mechanisms and roles in pathology. Int Rev Exp Pathol 32:223-253, 1991.
25. ras. Mol Cell Biol 13:155-162, 1993.
26. 1 Cancer Res 55:2978-2980, 1995.